Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2376 - 2400 of 3913 in total
Main Class Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR03
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260750 1631.949827 C78H141N3O32
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF03
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type II A antigen(d18:1/20:0)
44261014 1631.949827 C78H141N3O32
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG03
  • ClcNAc-Lex-5(d18:1/20:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261438 1631.949827 C78H141N3O32
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CU03
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type II A antigen(d18:1/20:0)
44261542 1631.949827 C78H141N3O32
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BI03
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261694 1631.949827 C78H141N3O32
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI05
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Leb(d18:1/24:0)
44260680 1630.990963 C80H146N2O31
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG05
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Ley-6(d18:1/24:0)
44261024 1630.990963 C80H146N2O31
Acidic glycosphingolipids Gangliosides LMSP0601AH05
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262024 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601AP05
  • GM1(d18:1/24:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262088 84671 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601AY05
  • GM1b(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262160 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601BM05
  • GM1alpha(d18:1/24:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262272 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DK05
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl-lactotetraosylceramide(d18:1/24:0)
44262632 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DY05
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl(2-6)lactotetraosylceramide(d18:1/24:0)
44262736 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DZ05
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262744 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601ED05
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262776 1629.970562 C79H143N3O31
Acidic glycosphingolipids Gangliosides LMSP0601EF05
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialosylparagloboside(d18:1/24:0)
44262792 1629.970562 C79H143N3O31
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI07
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Leb(d18:1/24:1(15Z))
44260682 1628.975313 C80H144N2O31
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG07
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Ley-6(d18:1/24:1(15Z))
44261026 1628.975313 C80H144N2O31
Acidic glycosphingolipids Gangliosides LMSP0601AH07
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262026 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601AP07
  • GM1(d18:1/24:1(15Z))
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262090 84673 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601AY07
  • GM1b(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262162 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601BM07
  • GM1alpha(d18:1/24:1(15Z))
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262274 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DK07
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • sialyl-lactotetraosylceramide(d18:1/24:1(15Z))
44262634 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DY07
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • sialyl(2-6)lactotetraosylceramide(d18:1/24:1(15Z))
44262738 1627.954912 C79H141N3O31
Acidic glycosphingolipids Gangliosides LMSP0601DZ07
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262746 1627.954912 C79H141N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024